Potential of the Private Prescription Market in Europe

This white paper examines the potential of the private and self-payer prescription market in Europe, focusing on the rise of Anti-Obesity Medications (AOMs) as a significant factor in this evolving landscape. It discusses the pressures faced by European healthcare systems, including budget constraints and capacity limitations, which are prompting patients to seek alternatives to public healthcare. The paper provides a comparative overview of healthcare coverage and reimbursement structures across various European countries, highlighting the role of private health insurance and digital health platforms in shaping treatment access. It outlines the dynamics of patient-led demand and the strategic opportunities for pharmaceutical companies presented by the growing AOM market. Additionally, the document details the challenges faced by healthcare systems and the implications of increasing out-of-pocket expenditures for patients. Overall, it presents a comprehensive analysis of the factors influencing the private prescription market in Europe and the potential for growth within this sector.